Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

Javier Rodríguez‐Ubreva, Anna Arutyunyan, Marc Jan Bonder, Lucía del Pino Molina, Stephen J. Clark, Carlos de la Calle‐Fabregat, Luz García‐Alonso, Louis‐François Handfield, Laura Ciudad, Eduardo Andrés‐León, Felix Krueger, Francesc Català‐Moll, Virginia Rodríguez-Cortez, Krzysztof Polański, Lira Mamanova, Stijn van Dongen, Vladimir Yu Kiselev, María T. Martínez-Saavedra, Holger Heyn, Javier Martı́n, Klaus Warnatz, Eduardo López‐Granados, Carlos Rodríguez‐Gallego, Oliver Stegle, Gavin Kelsey, Roser Vento‐Tormo, Esteban BallestarNature Communications 2022 · DOI

TL;DR

This study uses single-cell multi-omics to reveal widespread epigenetic dysregulation in memory B cells of individuals with Common Variable Immunodeficiency (CVID), particularly affecting germinal center reactions. These epigenetic changes correlate with transcriptional defects and altered immune cell communication, offering new insights into CVID pathogenesis and potential therapeutic targets.

What Problem Does This Paper Address?

Common Variable Immunodeficiency (CVID) is a prevalent primary immunodeficiency characterized by impaired antibody production and increased susceptibility to infections. While genetic factors are known, they only explain a fraction of CVID cases, suggesting that other mechanisms, like epigenetics, play a significant role. The disease's variable presentation and incomplete genetic penetrance point to complex underlying causes. Previous studies hinted at epigenetic involvement, but a comprehensive, single-cell understanding of how these epigenetic changes impact B cell development and function in CVID was lacking. This paper aims to bridge this gap by creating a detailed single-cell atlas of epigenetic and transcriptional alterations in CVID, focusing on B cell differentiation.

Methods

The researchers employed a multi-omics approach at the single-cell level. Key techniques included:

  • Single-cell whole-genome bisulfite sequencing (scBS-seq): To map DNA methylation patterns in individual B cells.
  • Single-cell ATAC-seq (scATAC-seq): To assess chromatin accessibility, indicating regulatory element activity.
  • Single-cell RNA sequencing (scRNA-seq): To profile gene expression in individual cells, both in steady-state and after in vitro activation.
  • Whole-genome sequencing (WGS): To rule out genetic causes for discordance in monozygotic twins.
  • Amplicon sequencing: To validate specific DNA methylation alterations in a larger cohort.
  • CellPhoneDB: A computational tool to infer cell-cell communication networks based on ligand-receptor interactions from scRNA-seq data.

Novel aspects include the integration of these multi-omics datasets at the single-cell level to dissect the complex interplay between epigenetics, transcription, and cell communication in CVID.

Datasets

The study utilized datasets from:

  • A pair of monozygotic (MZ) twins discordant for CVID: This provided a unique opportunity to study epigenetic contributions by controlling for genetic background.
  • A cohort of 10 CVID patients and 10 healthy donors: Used for validation of findings from the twin study.
  • Publicly available datasets: Including RNA-seq and ChIP-seq data for various B cell subsets from the Blueprint Consortium, and TF binding data from other sources.

Key Insights and Ideas

  • Epigenetic defects are B-cell intrinsic and memory-stage specific: The most significant DNA methylation and chromatin accessibility alterations were found in memory B cells, not in naïve B cells, suggesting these defects are acquired during B cell differentiation.
  • Germinal Center (GC) reaction is epigenetically perturbed: CVID-associated epigenetic changes occurred in genomic regions and regulatory elements that are typically active during the GC reaction, a critical process for antibody maturation.
  • Impaired DNA demethylation: CVID memory B cells showed a deficit in DNA demethylation, particularly in non-partially methylated domains (non-PMDs), suggesting issues with active demethylation mechanisms.
  • Heterogeneous epigenetic landscape: While widespread, the epigenetic defects in CVID memory B cells were heterogeneous, with some cells retaining profiles similar to controls, indicating a complex disease state.
  • Transcriptional dysregulation upon activation: Steady-state B cells showed similar transcriptional profiles between CVID and control twins, but upon activation, CVID memory B cells exhibited significant transcriptional differences, particularly in genes related to immune response and cell communication.
  • Altered immune cell communication: The study identified dysregulated ligand-receptor interactions involving B cells and other immune cells, suggesting a breakdown in coordinated immune responses.

Key Results

  • DNA Methylation: Significant differences in DNA methylation were observed in CVID memory B cells, with a notable impairment in DNA demethylation during the transition to switched memory (S-mem) B cells.
  • Chromatin Accessibility: CVID memory B cells showed altered chromatin accessibility in regulatory regions, particularly those associated with active enhancers during B cell activation.
  • Transcriptomics: Activated memory B cells from CVID patients displayed a significant number of dysregulated genes (over 5000), including those involved in B cell receptor signaling and immune regulation.
  • Cell-cell Communication: Defective ligand-receptor pairs were identified, with some negative regulators of B cell function being upregulated in CVID B cells.
  • Validation: Key findings from the twin study, such as hypermethylation in S-mem B cells and dysregulated gene expression, were validated in the larger CVID patient cohort.

Limitations and Future Work

  • Cohort Size: The study acknowledges the limited size of the CVID patient cohort, particularly for specific subtypes (Ia and II), and notes that analyses were primarily based on peripheral blood, potentially missing features present in secondary lymphoid organs.
  • In Vitro Activation: The use of in vitro activated B cells to emulate the GC reaction is a necessary but not perfect representation of in vivo processes.
  • TET Enzyme Activity: While TET enzyme expression was normal, defects in their activity or recruitment to specific sites were hypothesized but not directly measured.
  • Future Work: The authors suggest that the identified epigenetic signatures could serve as diagnostic markers for CVID. Further research could explore the precise mechanisms of altered demethylation and the functional consequences of dysregulated cell-cell communication in vivo. The development of targeted epigenetic therapies for CVID is also a promising avenue.

Summary updated

Abstract

Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. Here, we generate a single-cell epigenomics and transcriptomics census of naïve-to-memory B cell differentiation in a CVID-discordant MZ twin pair. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B-cells mirroring defective cell-cell communication upon activation. These findings are validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naïve-to-memory B-cell transition in CVID and indicate links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, gives insight into future diagnosis and treatments of CVID patients.
BibTeX
@inproceedings{rodriguezubreva2022single,
  author = {Javier Rodríguez‐Ubreva and Anna Arutyunyan and Marc Jan Bonder and Lucía del Pino Molina and Stephen J. Clark and Carlos de la Calle‐Fabregat and Luz García‐Alonso and Louis‐François Handfield and Laura Ciudad and Eduardo Andrés‐León and Felix Krueger and Francesc Català‐Moll and Virginia Rodríguez-Cortez and Krzysztof Polański and Lira Mamanova and Stijn van Dongen and Vladimir Yu Kiselev and María T. Martínez-Saavedra and Holger Heyn and Javier Martı́n and Klaus Warnatz and Eduardo López‐Granados and Carlos Rodríguez‐Gallego and Oliver Stegle and Gavin Kelsey and Roser Vento‐Tormo and Esteban Ballestar},
  title = {{Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-022-29450-x},
}
Figure